<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2011-07-20T00:29:38Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:2806018" metadataPrefix="pmc">http://www.pubmedcentral.nih.gov/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:2806018</identifier><datestamp>2010-02-12</datestamp><setSpec>aging</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="review-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Aging (Albany NY)</journal-id>
      <journal-id journal-id-type="publisher-id">ImpactJ</journal-id>
      <journal-title-group>
        <journal-title>Aging</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1945-4589</issn>
      <publisher>
        <publisher-name>Impact Journals LLC</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">2806018</article-id>
      <article-id pub-id-type="pmid">20157523</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Growth and aging: a common molecular mechanism</article-title>
        <alt-title alt-title-type="running-head">Growth and aging</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Blagosklonny</surname>
            <given-names>Mikhail V.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hall</surname>
            <given-names>Michael N.</given-names>
          </name>
          <xref ref-type="aff" rid="A2">
            <sup>2</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><sup>1</sup>Roswell Park Cancer
                    Institute, Buffalo, NY 14263, USA
            </aff>
      <aff id="A2"><sup>2</sup>Biozentrum,
                    University of Basel, CH4056 Basel, Switzerland
            </aff>
      <author-notes>
        <corresp id="cor1"><bold>Correspondence: </bold>Mikhail
                        V. Blagosklonny, MD,PhD, Roswell Park Cancer Institute, Elm &amp; Carlton
                        Streets, Buffalo, NY 14263, USA; Michael N. Hall, PhD, Biozentrum,
                        University of Basel, CH4056 Basel, Switzerland <email>blagosklonny@oncotarget.com</email><email>m.hall@unibas.ch</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>4</month>
        <year>2009</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>4</month>
        <year>2009</year>
      </pub-date>
      <volume>1</volume>
      <issue>4</issue>
      <fpage>357</fpage>
      <lpage>362</lpage>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>2</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>4</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: Â©2009 Blagosklonny et al.</copyright-statement>
        <copyright-year>2009</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>
                        It is commonly assumed that growth and aging are somehow linked, but the
                        nature of this link has been elusive.   Here we review the aging process as
                        a continuation of TOR-driven growth. TOR is absolutely essential for
                        developmental growth, but upon completion of development it causes aging
                        and age-related diseases.  Thus, the nutrient-sensing and growth-promoting
                        TOR signaling pathway may provide a molecular link between growth and aging
                        that is universal from yeast to human.
                </p>
      </abstract>
      <kwd-group>
        <kwd>aging</kwd>
        <kwd>growth</kwd>
        <kwd>rapamycin</kwd>
        <kwd>TOR</kwd>
        <kwd>mitochondria</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s1" sec-type="intro">
      <title>Introduction</title>
      <p>
                    At first glance, growth and aging appear
                        to be opposites.  Growth is energy-driven synthesis of macromolecules from
                        simple nutrients, an increase of order and a decrease of entropy.  Aging is
                        decay, a loss of order and a rise of entropy.  Seemingly, growth and aging are
                        mutually exclusive.  Forever proliferating cells, such as legendary hydras, do
                        not show signs of aging.  In contrast, when an organism ceases to grow, aging
                        follows.  However, manipulations that decrease growth also decrease aging and
                        prolong life span.  For example, calorie restriction (reduced nutrient intake)
                        reduces growth and increases longevity in diverse species from yeast to mice. 
                        Rapamycin, which inhibits growth in yeast, decelerates yeast aging.  Inactivation
                        of the growth-promoting insulin/IGF-1 signaling pathway increases life span,
                        from worms to mice.  Why do growth-inhibiting conditions slow down aging?  Are
                        growth and aging mechanistically similar?  As
                        we discuss here, growth and aging may not be opposites but rather a
                        continuation of one another driven by the same molecular pathway.  Aging and
                        growth may be linked in a way that growth produces aging.  In
                        other words, excessive growth is a driving force for aging.  The molecular
                        pathway that drives both growth and aging appears to be the evolutionarily
                        conserved TOR (target of rapamycin) pathway.
                    
            </p>
      <sec id="s1_1">
        <title>The TOR pathway
                        </title>
        <p>TOR (Target Of Rapamycin), as its name indicates, was
                            originally discovered, in yeast, as the target of the antifungal drug rapamycin. 
                            Rapamycin is a natural secondary metabolite produced by soil bacteria to
                            inhibit growth of fungal competitors.  Thus, it is a mirror image of penicillin
                            that is produced by fungi to inhibit bacterial growth.  Remarkably, TOR is
                            structurally and functionally conserved from yeast to human (including worms,
                            flies, plants and mice) as an essential, central controller of cell growth [<xref ref-type="bibr" rid="R1">1</xref>].
                            TOR in mammals (mTOR) controls cell growth and metabolism in response to
                            nutrients (e.g., amino acids), growth factors (e.g., insulin, IGF-1, PDGF), and
                            cellular energy status (ATP).  Nutrients are the dominant TOR input as high
                            levels of amino acids can compensate for an absence of the other mTOR inputs
                            but not vice versa [<xref ref-type="bibr" rid="R2">2</xref>], and only nutrients activate TOR in unicellular
                            organisms.  The growth factor signaling pathway, grafted onto the more
                            ancestral nutrient sensitive TOR pathway, co-evolved with multicellularity. 
                            TOR activates cell growth by positively and negatively regulating several
                            anabolic and catabolic processes, respectively, that collectively determine mass
                            accumulation.  The anabolic processes include transcription, protein
                            synthesis, ribosome biogenesis, nutrient transport, and mitochondrial
                            metabolism.  Conversely, TOR negatively regulates catabolic processes such as
                            mRNA degradation, ubiquitin-dependent proteolysis, and autophagy.  TOR is an
                            atypical serine/threonine kinase that is found in two functionally and
                            structurally distinct multiprotein complexes, TORC1 and TORC2 (mTORC1 and
                            mTORC2 in mammals), each of which signals via a different set of effector
                            pathways.   TORC1 is rapamycin sensitive whereas TORC2 is rapamycin
                            insensitive.  The best-characterized phosphorylation substrates of mTOR are S6K
                            and 4E-BP1 via which mTORC1 controls translation, and Akt/PKB via which mTORC2
                            controls cell survival and other processes [<xref ref-type="bibr" rid="R3">3</xref>].  Like TOR itself, the two TOR
                            complexes and the overall architecture of the TOR signaling network appear to
                            be conserved from yeast to human [<xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R4">4</xref>].  TOR and many of the processes it
                            controls have also been shown to play a role in aging (in addition to growth)
                            in a wide variety of organisms, as described below.
                        
                </p>
      </sec>
      <sec id="s1_2">
        <title>Aging in budding yeast
                        </title>
        <p>Budding yeast <italic>S. cerevisiae</italic> is a particularly
                            useful model system to study aging because it can be used to study both
                            replicative aging and chronological aging.  Replicative aging is measured by
                            the number of daughter cells (divisions) a mother cell can produce. 
                            Chronological aging, also referred to as postmitotic aging, is measured by the
                            length of time a non-dividing cell can survive.  Inhibition of TORC1 signaling
                            in yeast extends both replicative [<xref ref-type="bibr" rid="R5">5</xref>] and chronological [<xref ref-type="bibr" rid="R6">6</xref>] life span. Thus,
                            TOR appears to promote aging regardless of physiological context (mitotic or
                            post-mitotic cells).
                        
                </p>
        <p>In yeast, the link between growth and
                            aging has been known sinse the 1950's is particularly spectacular. Yeast cells
                            grow larger as they grow older [<xref ref-type="bibr" rid="R7">7</xref>,<xref ref-type="bibr" rid="R8">8</xref>]<bold>. </bold>The yeast <italic>S. cerevisiae</italic>
                            typically divides asymmetrically to give a large mother cell and a smaller
                            daughter cell. As mother cells become old, they enlarge and produce daughter
                            cells that are larger than daughters derived from young mother cells. Like
                            large mothers, large daughter cells have shorter replicative life span [<xref ref-type="bibr" rid="R8">8</xref>].
                        
                </p>
        <p>The use of unicellular yeast to study aging is
                            revealing also because here the cell is the organism.  Therefore, it is a model
                            for cell aging and organismal longevity.  As we discuss below, TOR also
                            controls longevity in multicellular organisms.
                        
                </p>
      </sec>
      <sec id="s1_3">
        <title>TOR and aging from worm to mammals 
                        </title>
        <p>Inhibition of TOR signaling enhances life span in
                            worms, flies and possibly mammals.  The nematode <italic>C. elegans</italic> contains a
                            constant number of post-mitotic cells and lives about twenty days. The
                            first demonstration that TOR controls life span was by Vellai et al [<xref ref-type="bibr" rid="R9">9</xref>] who
                            showed that knocking down TOR in  <italic>-C. elegans</italic> more than doubles this
                            worm's normal life span. They examined specifically the role of TOR in aging
                            based on the prior knowledge that both TOR and life span are regulated by
                            nutrients and insulin.  Indeed, a large body of earlier, groundbreaking work
                            showing that calorie restriction [<xref ref-type="bibr" rid="R10">10</xref>,<xref ref-type="bibr" rid="R11">11</xref>] or down regulation of insulin/IGF-1
                            signaling [<xref ref-type="bibr" rid="R12">12</xref>,<xref ref-type="bibr" rid="R13">13</xref>] extends life span is consistent with the observation that
                            down regulation of TOR also extends life span.  Interestingly, inhibition of
                            TOR starting either during development or on the first day of adulthood gives
                            comparable life span extension, suggesting that TOR controls longevity mainly,
                            if not exclusively, during adulthood [<xref ref-type="bibr" rid="R9">9</xref>].  Jia et al. [<xref ref-type="bibr" rid="R14">14</xref>] subsequently
                            demonstrated that worms deficient in raptor, a TORC1-specific subunit, also
                            have an extended life span, indicating that TOR promotes aging via at least
                            TORC1, if not via both TORCs.
                        
                </p>
        <p> In <italic>Drosophila</italic>, TOR is required for growth
                            during larval development, and for increases in cellular growth caused by
                            growth factor signaling and nutrient availability [<xref ref-type="bibr" rid="R15">15</xref>]. Genetic inhibition of
                            the <italic>Drosophila</italic> TOR pathway, either upstream or downstream of TOR,
                            extends life span [<xref ref-type="bibr" rid="R16">16</xref>,<xref ref-type="bibr" rid="R17">17</xref>].  Furthermore, reducing the function of <italic>Drosophila</italic>
                            TOR results in decreased lipid stores and glucose levels, and prevents
                            metabolic syndrome [<xref ref-type="bibr" rid="R18">18</xref>].  The life span extension is observed upon down
                            regulation of TOR signaling in the fat body [<xref ref-type="bibr" rid="R17">17</xref>], underscoring the importance
                            of fat in aging [<xref ref-type="bibr" rid="R19">19</xref>-<xref ref-type="bibr" rid="R21">21</xref>,<xref ref-type="bibr" rid="R12">12</xref>]. Downregulating TOR signaling in the fat body not
                            only extends the life of the fly, it also reduces the size of the entire
                            organism [<xref ref-type="bibr" rid="R22">22</xref>], providing yet another link between growth and aging. The
                            apparently central role of TOR signaling in the fly fat body in regulating life
                            span may be recapitulated by mammalian TOR in adipose tissue.  In mice,
                            decreased insulin/IGF-1 signaling in adipose tissue, and consequently less
                            active downstream mTOR signaling, increases life span [<xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R20">20</xref>]. Furthermore,
                            adult-onset growth hormone or IGF-1 deficiency increases life span in rodents
                            [<xref ref-type="bibr" rid="R24">24</xref>].  Also, mice deficient for mTORC1 or the mTORC1 effector S6K are protected
                            against age- and diet-induced obesity [<xref ref-type="bibr" rid="R25">25</xref>,<xref ref-type="bibr" rid="R26">26</xref>]. Rapamycin is currently being
                            tested for its ability to extend lifespan in mice in the National Interventions
                            Testing Program.
                        
                </p>
        <p>Finally, calorie restriction, in which nutrient intake
                            is restricted to 60-70% that of voluntary levels, increases life span in most
                            species including mammals [<xref ref-type="bibr" rid="R10">10</xref>-<xref ref-type="bibr" rid="R12">12</xref>]. Although anti-aging mechanisms of CR are
                            still disputed, one of the mechanisms is likely inactivation of the TOR
                            pathway. Indeed, taking into account that i) inhibition of TOR extends life
                            span and ii) nutrients activate TOR, the mechanism of how restriction of
                            nutrients can increase life span seems apparent.
                        
                </p>
      </sec>
      <sec id="s1_4">
        <title>Downstream of TOR</title>
        <p>
                        How does TOR promote aging in response to nutrients? 
                            In other words, which of the many TORC1-controlled processes that are either up
                            regulated or down regulated upon nutrient deprivation (TORC1 inactivation)
                            leads to longer life?  Recent evidence suggests that TORC1 controls aging via
                            several of its downstream processes, including autophagy, ribosome biogenesis
                            and protein synthesis, transcription, and mitochondrial activity.  Indeed,
                            there is a remarkable correlation between TOR-controlled processes and
                            processes in aging.  It is also important to note that these processes
                            constitute the normal program via which TOR controls cell growth, suggesting
                            that TOR control of aging is an extension or continuation of its control of
                            growth.
                        
                </p>
        <p>TORC1 inhibits autophagy, a process of bulk
                            degradation of proteins and organelles by lysosomes [<xref ref-type="bibr" rid="R27">27</xref>].  Autophagy is
                            inhibited in aging and age-related diseases [<xref ref-type="bibr" rid="R28">28</xref>]. Restoration of autophagy
                            depletes mitochondria with deleterious mtDNA mutations but spares their normal
                            counterparts [<xref ref-type="bibr" rid="R29">29</xref>]. Furthermore,  autophagy is essential for life span extension
                            at least in worms [<xref ref-type="bibr" rid="R30">30</xref>]. This suggests that TORC1 promotes aging in part via
                            inhibition of autophagy.
                        
                </p>
        <p> TORC1 activates ribosome biogenesis and protein
                            synthesis. Recent studies show that inhibition of ribosome biogenesis and
                            global protein synthesis extends life span [<xref ref-type="bibr" rid="R31">31</xref>-<xref ref-type="bibr" rid="R34">34</xref>].  Reducing the levels of
                            ribosomal proteins and translation initiation factors extends life span in both
                            yeast and worms.  Thus, this is consistent with the notion that TORC1 may
                            promote aging via activation of ribosome biogenesis and protein synthesis.
                        
                </p>
        <p>TORC1 in yeast negatively regulates the
                            stress-activated transcription factors GIS1 and MSN2/4.  Both transcription
                            factors are required for life span extension upon down regulation of TOR [<xref ref-type="bibr" rid="R35">35</xref>,<xref ref-type="bibr" rid="R36">36</xref>]. A longevity-related gene up regulated by MSN2/4 upon TOR inhibition is the
                            nicotinamidase gene <italic>PCN1</italic>.  Interestingly, nicotinamidase converts
                            nicotinamide to NAD<sup>+</sup> which in turn activates SIR2, suggesting that
                            TOR and sirtuins are part of the same longevity pathway [<xref ref-type="bibr" rid="R35">35</xref>].  Furthermore, as
                            discussed below, TOR negatively regulates mitochondrial gene expression to
                            limit life span [<xref ref-type="bibr" rid="R37">37</xref>].
                        
                </p>
        <p>TORC1 controls mitochondrial activity, but in
                            different ways depending on the organism.  In yeast, TORC1 inhibits
                            mitochondrial respiration whereas in mammals (at least in muscle) it stimulates
                            respiration [<xref ref-type="bibr" rid="R37">37</xref>-<xref ref-type="bibr" rid="R42">42</xref>].  This divergence in regulation is probably related to the
                            fact that glucose, a nutrient sensed by TORC1, triggers anaerobic fermentation
                            in yeast.  A similar glucose-dependent shift in respiration does not occur in
                            mammals.  Consistent with the above, increased mitochondrial respiration
                            extends life span in yeast whereas in mammalian cells life span extension
                            correlates with reduced respiration [<xref ref-type="bibr" rid="R37">37</xref>,<xref ref-type="bibr" rid="R39">39</xref>,<xref ref-type="bibr" rid="R43">43</xref>].  However, the role of
                            mitochondria in life span extension remains elusive, particularly with the
                            recent demonstration that TORC1 in mammalian adipose tissue, like in yeast,
                            negatively controls respiration [<xref ref-type="bibr" rid="R26">26</xref>].
                        
                </p>
        <p>Accumulation of aggregation-prone proteins is involved
                            in neurodegeneration. TOR causes neurodegeneration in a <italic>Drosophila</italic>
                            tauopathy model [<xref ref-type="bibr" rid="R44">44</xref>]. The TOR pathway is involved in Alzheimer's disease by
                            increasing Tau protein synthesis [<xref ref-type="bibr" rid="R45">45</xref>].  Furthermore, rapamycin enhances
                            clearance of pathologic proteins and thereby reduces their toxicity [<xref ref-type="bibr" rid="R46">46</xref>].
                        
                </p>
        <p>As we discuss below, overactive TOR seems to be
                            involved in the hypertrophic phenotype of aging mammalian cells, thus linking
                            TOR mediated cell hypertrophy to organismal aging. In contrast, a replicative
                            limit has never been shown to be important <italic>in vivo</italic> [<xref ref-type="bibr" rid="R47">47</xref>]. It is a
                            hyperthropic, secretory phenotype of aging cells that can be linked to organismal
                            aging [<xref ref-type="bibr" rid="R48">48</xref>-<xref ref-type="bibr" rid="R50">50</xref>].
                        
                </p>
      </sec>
      <sec id="s1_5">
        <title>Hypertrophic phenotype of aging cells
                        </title>
        <p>If growth and aging are mechanistically linked, are
                            older cells larger?  In yeast, old cells are large and cell size predicts
                            replicative life span [<xref ref-type="bibr" rid="R51">51</xref>,<xref ref-type="bibr" rid="R52">52</xref>]. This also appears to be the case for senescent
                            mammalian cells.  An increase in cell size is a hallmark of senescent
                            fibroblasts [<xref ref-type="bibr" rid="R53">53</xref>]. Their cell volume is several fold greater compared with
                            proliferating cells. Cell size is progressively increased in cell culture as
                            cells progress toward senescence [<xref ref-type="bibr" rid="R54">54</xref>-<xref ref-type="bibr" rid="R56">56</xref>]. Furthermore, it was suggested 20
                            years ago that cell size is a marker of cell senescence [<xref ref-type="bibr" rid="R54">54</xref>,<xref ref-type="bibr" rid="R57">57</xref>]. Ironically,
                            TOR had not been discovered at that time and the significance of this
                            phenomenological observation was unclear. The notion that TOR is involved in
                            both growth and aging now provides a mechanistic explanation for an old
                            observation.
                        
                </p>
        <p>Cell growth is an increase in cell volume, or mass,
                            due to metabolic activity including synthesis of macromolecules (RNA, protein,
                            lipid) and organelles.  If a cell grows without division, it becomes hypertrophic. 
                            In other words, when the cell cycle is blocked in the presence of
                            growth-promoting signaling, then cells increase in size [<xref ref-type="bibr" rid="R56">56</xref>,<xref ref-type="bibr" rid="R58">58</xref>,<xref ref-type="bibr" rid="R59">59</xref>].
                        
                </p>
        <p>Thus, cell growth is counterbalanced by cell division
                            such that cells maintain a characteristic size.  The simplest way to cause both
                            cell hypertrophy and cell senescence is to prevent cell division without
                            inhibiting cell growth. Inhibition of mTOR with rapamycin decreases the
                            hypertrophic cell phenotype caused by induction of the CDK inhibitor p21
                            [<xref ref-type="bibr" rid="R58">58</xref>-<xref ref-type="bibr" rid="R60">60</xref>].
                        
                </p>
        <p>All these observations suggest that mTOR signaling
                            plays a role in aging of single cells.  How is this related to aging of
                            multicellular organisms?  As discussed elsewhere [<xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R61">61</xref>], TOR-driven alterations
                            can be linked to metazoan aging and, in particular, diseases of aging such as
                            cancer, metabolic syndrome, atherosclerosis, hypertension and hypertrophic
                            heart.
                        
                </p>
      </sec>
      <sec id="s1_6">
        <title>Rapamycin in humans
                        </title>
        <p>Rapamycin is given to renal transplant patients
                            everyday for several years to prevent organ rejection.  We view this as an
                            unintentional clinical trial of a potentially anti-aging drug. First, in such
                            patients, rapamycin unexpectedly turned out to prevent cancer [<xref ref-type="bibr" rid="R62">62</xref>-<xref ref-type="bibr" rid="R64">64</xref>] and even
                            cured some types of pre-existing tumors [<xref ref-type="bibr" rid="R65">65</xref>,<xref ref-type="bibr" rid="R66">66</xref>]. Second, 2 years after
                            transplantation, body-mass index was significantly lower in the rapamycin-based
                            treatment arm compared to cyclosporine, indicating that rapamycin prevents obesity
                            [<xref ref-type="bibr" rid="R67">67</xref>].
                        
                </p>
        <p>Rapamycin is safe enough to be used in
                            healthy volunteers to study its pharmacokinetics [<xref ref-type="bibr" rid="R68">68</xref>-<xref ref-type="bibr" rid="R70">70</xref>].  In healthy
                            volunteers, a single dose was not associated with side effects. In 11 healthy
                            men (29 years old, BMI 23 kg/m<sup>2</sup>), 6 mg of rapamycin decreased
                            S6K phosphorylation, preventing insulin resistance caused by nutrients. Thus,
                            the activity state of the mTOR pathway can modulate insulin sensitivity in
                            humans and mTOR inhibitors prevent nutrient-induced insulin resistance [<xref ref-type="bibr" rid="R70">70</xref>].
                        
                </p>
      </sec>
      <sec id="s1_7">
        <title>Why TOR? </title>
        <p>Cell growth and division are the two most fundamental
                            features of life. Using simple compounds and energy, living organisms build
                            macromolecules according to their own plan, transforming non-self to self.  Not
                            surprisingly, the growth-controlling TOR signaling pathway is conserved from
                            yeast to human.  In unicellular organisms, it maximizes growth as long as
                            nutrients are available.  However, life-promoting TOR signaling seems also to
                            contain seeds of death.  Aging and its manifestations such as age-related
                            diseases appear with excessive growth-promoting signaling, when actual growth
                            is not longer possible. Aging is not programmed, of course, but is an aimless
                            continuation of the same process that drives developmental growth. Since aging
                            does not limit life span in the wild, switch-off of this âgrowth program'
                            cannot evolve.  Growth should be robust and not be slowed down to avoid aging.
                            Furthermore, the aging-growth program cannot be switched off by an accidental
                            mutation, because such a mutation would be lethal or at least reduce fitness
                            during development.  Yet, TOR can be inhibited pharmacologically.
                        
                </p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <p>M.N.H. acknowledges support from the Swiss National
                        Science Foundation and the Canton of Basel.
                    
            </p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Wullschleger</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Loewith</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Hall</surname>
            <given-names>MN</given-names>
          </name>
          <article-title>TOR signaling in growth and metabolism</article-title>
          <source>Cell</source>
          <year>2006</year>
          <volume>124</volume>
          <fpage>471</fpage>
          <lpage>484</lpage>
          <pub-id pub-id-type="pmid">16469695</pub-id>
        </element-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Avruch</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hara</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Long</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Ortiz-Vega</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yonezawa</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase</article-title>
          <source>Oncogene</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>6361</fpage>
          <lpage>6372</lpage>
          <pub-id pub-id-type="pmid">17041622</pub-id>
        </element-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Manning</surname>
            <given-names>BD</given-names>
          </name>
          <name>
            <surname>Cantley</surname>
            <given-names>LC</given-names>
          </name>
          <article-title>AKT/PKB signaling: navigating downstream</article-title>
          <source>Cell</source>
          <year>2007</year>
          <volume>129</volume>
          <fpage>1261</fpage>
          <lpage>1274</lpage>
          <pub-id pub-id-type="pmid">17604717</pub-id>
        </element-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Powers</surname>
            <given-names>T</given-names>
          </name>
          <article-title>TOR signaling and S6 kinase 1: Yeast catches up</article-title>
          <source>Cell Metab</source>
          <year>2007</year>
          <volume>6</volume>
          <fpage>1</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="pmid">17618850</pub-id>
        </element-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Kaeberlein</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Powers</surname>
            <given-names>RW</given-names>
          </name>
          <name>
            <surname>Steffen</surname>
            <given-names>KK</given-names>
          </name>
          <name>
            <surname>Westman</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Dang</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kerr</surname>
            <given-names>EO</given-names>
          </name>
          <name>
            <surname>Kirkland</surname>
            <given-names>KT</given-names>
          </name>
          <name>
            <surname>Fields</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kennedy</surname>
            <given-names>BK</given-names>
          </name>
          <article-title>Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients</article-title>
          <source>Science</source>
          <year>2005</year>
          <volume>310</volume>
          <fpage>1193</fpage>
          <lpage>1196</lpage>
          <pub-id pub-id-type="pmid">16293764</pub-id>
        </element-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Powers</surname>
            <given-names>RW</given-names>
          </name>
          <name>
            <surname>Kaeberlein</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Caldwell</surname>
            <given-names>SD</given-names>
          </name>
          <name>
            <surname>Kennedy</surname>
            <given-names>BK</given-names>
          </name>
          <name>
            <surname>Fields</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Extension of chronological life span in yeast by decreased TOR pathway signaling</article-title>
          <source>Genes Dev</source>
          <year>2006</year>
          <volume>20</volume>
          <fpage>174</fpage>
          <lpage>184</lpage>
          <pub-id pub-id-type="pmid">16418483</pub-id>
        </element-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Austriaco</surname>
            <given-names>NRJ</given-names>
          </name>
          <article-title>Review: to bud until death: the genetics of ageing in the yeast, Saccharomyces</article-title>
          <source>Yeast</source>
          <year>1996</year>
          <volume>12</volume>
          <fpage>623</fpage>
          <lpage>630</lpage>
          <pub-id pub-id-type="pmid">8810036</pub-id>
        </element-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Kennedy</surname>
            <given-names>BK</given-names>
          </name>
          <name>
            <surname>Austriaco</surname>
            <given-names>NRJ</given-names>
          </name>
          <name>
            <surname>Guarente</surname>
            <given-names>L</given-names>
          </name>
          <article-title>Daughter cells of Saccharomyces cerevisiae from old mothers display a reduced life span</article-title>
          <source>J Cell Biol</source>
          <year>1994</year>
          <volume>127</volume>
          <fpage>1985</fpage>
          <lpage>1993</lpage>
          <pub-id pub-id-type="pmid">7806576</pub-id>
        </element-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Vellai</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Takacs-Vellai</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kovacs</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Orosz</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Muller</surname>
            <given-names>F</given-names>
          </name>
          <article-title>Genetics: influence of TOR kinase on lifespan in C. elegans</article-title>
          <source>Nature</source>
          <year>2003</year>
          <volume>426</volume>
          <fpage>620</fpage>
          <pub-id pub-id-type="pmid">14668850</pub-id>
        </element-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Bordone</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Guarente</surname>
            <given-names>L</given-names>
          </name>
          <article-title>Calorie restriction, SIRT1 and metabolism: understanding longevity</article-title>
          <source>Nat Rev Mol Cell Biol</source>
          <year>2005</year>
          <volume>6</volume>
          <fpage>298</fpage>
          <lpage>305</lpage>
          <pub-id pub-id-type="pmid">15768047</pub-id>
        </element-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Guarente</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Picard</surname>
            <given-names>F</given-names>
          </name>
          <article-title>Calorie restriction - the SIR2 connection</article-title>
          <source>Cell</source>
          <year>2005</year>
          <volume>120</volume>
          <fpage>473</fpage>
          <lpage>482</lpage>
          <pub-id pub-id-type="pmid">15734680</pub-id>
        </element-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Kenyon</surname>
            <given-names>C</given-names>
          </name>
          <article-title>The plasticity of aging: insights from long-lived mutants</article-title>
          <source>Cell</source>
          <year>2005</year>
          <volume>120</volume>
          <fpage>449</fpage>
          <lpage>460</lpage>
          <pub-id pub-id-type="pmid">15734678</pub-id>
        </element-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Kimura</surname>
            <given-names>KD</given-names>
          </name>
          <name>
            <surname>Tissenbaum</surname>
            <given-names>HA</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Ruvkun</surname>
            <given-names>G</given-names>
          </name>
          <article-title>daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans</article-title>
          <source>Science</source>
          <year>1997</year>
          <volume>277</volume>
          <fpage>942</fpage>
          <lpage>946</lpage>
          <pub-id pub-id-type="pmid">9252323</pub-id>
        </element-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Jia</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Riddle</surname>
            <given-names>DL</given-names>
          </name>
          <article-title>The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span</article-title>
          <source>Development</source>
          <year>2004</year>
          <volume>131</volume>
          <fpage>3897</fpage>
          <lpage>3906</lpage>
          <pub-id pub-id-type="pmid">15253933</pub-id>
        </element-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Zhang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Stallock</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Ng</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Reinhard</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Neufeld</surname>
            <given-names>TP</given-names>
          </name>
          <article-title>Regulation of cellular growth by the Drosophila target of rapamycin dTOR</article-title>
          <source>Genes Dev</source>
          <year>2000</year>
          <volume>14</volume>
          <fpage>2712</fpage>
          <lpage>2724</lpage>
          <pub-id pub-id-type="pmid">11069888</pub-id>
        </element-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Tatar</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kopelman</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Epstein</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Tu</surname>
            <given-names>MP</given-names>
          </name>
          <name>
            <surname>Yin</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Garofalo</surname>
            <given-names>RS</given-names>
          </name>
          <article-title>A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function</article-title>
          <source>Science</source>
          <year>2001</year>
          <volume>292</volume>
          <fpage>107</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="pmid">11292875</pub-id>
        </element-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Kapahi</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Zid</surname>
            <given-names>BM</given-names>
          </name>
          <name>
            <surname>Harper</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Koslover</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Sapin</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Benzer</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway</article-title>
          <source>Curr Biol</source>
          <year>2004</year>
          <volume>14</volume>
          <fpage>885</fpage>
          <lpage>890</lpage>
          <pub-id pub-id-type="pmid">15186745</pub-id>
        </element-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Luong</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Davies</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Wessells</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Graham</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>King</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Veech</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bodmer</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Oldham</surname>
            <given-names>SM</given-names>
          </name>
          <article-title>Activated FOXO-mediated insulin resistance is blocked by reduction of TOR activity</article-title>
          <source>Cell Metab</source>
          <year>2006</year>
          <volume>4</volume>
          <fpage>133</fpage>
          <lpage>142</lpage>
          <pub-id pub-id-type="pmid">16890541</pub-id>
        </element-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Pinkston</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Garigan</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hansen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kenyon</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Mutations that increase the life span of C. elegans inhibit tumor growth</article-title>
          <source>Science</source>
          <year>2006</year>
          <volume>313</volume>
          <fpage>971</fpage>
          <lpage>975</lpage>
          <pub-id pub-id-type="pmid">16917064</pub-id>
        </element-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <element-citation publication-type="journal">
          <name>
            <surname>BlÃ¼her</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kahn</surname>
            <given-names>BB</given-names>
          </name>
          <name>
            <surname>Kahn</surname>
            <given-names>CR</given-names>
          </name>
          <article-title>Extended longevity in mice lacking the insulin receptor in adipose tissue</article-title>
          <source>Science</source>
          <year>2003</year>
          <volume>299</volume>
          <fpage>572</fpage>
          <lpage>574</lpage>
          <pub-id pub-id-type="pmid">12543978</pub-id>
        </element-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Guarente</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Kenyon</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Genetic pathways that regulate ageing in model organisms</article-title>
          <source>Nature</source>
          <year>2000</year>
          <volume>408</volume>
          <fpage>255</fpage>
          <lpage>262</lpage>
          <pub-id pub-id-type="pmid">11089983</pub-id>
        </element-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Colombani</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Raisin</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Pantalacci</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Radimerski</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Montagne</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>LÃ©opold</surname>
            <given-names>P</given-names>
          </name>
          <article-title>A nutrient sensor mechanism controls Drosophila growth</article-title>
          <source>Cell</source>
          <year>2003</year>
          <volume>114</volume>
          <fpage>739</fpage>
          <lpage>749</lpage>
          <pub-id pub-id-type="pmid">14505573</pub-id>
        </element-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Bartke</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Long-lived Klotho mice: new insights into the roles of IGF-1 and insulin in aging</article-title>
          <source>Trends Endocrinol Metab</source>
          <year>2006</year>
          <volume>17</volume>
          <fpage>33</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="pmid">16458526</pub-id>
        </element-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Sonntag</surname>
            <given-names>WE</given-names>
          </name>
          <name>
            <surname>Carter</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Ikeno</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Ekenstedt</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Carlson</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Loeser</surname>
            <given-names>RF</given-names>
          </name>
          <name>
            <surname>Chakrabarty</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bennett</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ingram</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Moore</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ramsey</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Adult-onset growth hormone and insulin-like growth factor I deficiency reduces neoplastic disease, modifies age-related pathology, and increases life span</article-title>
          <source>Endocrinology</source>
          <year>2005</year>
          <volume>146</volume>
          <fpage>2920</fpage>
          <lpage>2932</lpage>
          <pub-id pub-id-type="pmid">15790724</pub-id>
        </element-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Um</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Frigerio</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Watanabe</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Picard</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Joaquin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sticker</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Fumagalli</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Allegrini</surname>
            <given-names>PR</given-names>
          </name>
          <name>
            <surname>Kozma</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Auwerx</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity</article-title>
          <source>Nature</source>
          <year>2004</year>
          <volume>431</volume>
          <fpage>200</fpage>
          <lpage>205</lpage>
          <pub-id pub-id-type="pmid">15306821</pub-id>
        </element-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Polak</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Cybulski</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Feige</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Auwerx</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>RÃ¼egg</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Hall</surname>
            <given-names>MN</given-names>
          </name>
          <article-title>Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration</article-title>
          <source>Cell Metab</source>
          <year>2008</year>
          <volume>8</volume>
          <fpage>399</fpage>
          <lpage>410</lpage>
          <pub-id pub-id-type="pmid">19046571</pub-id>
        </element-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Klionsky</surname>
            <given-names>DJ</given-names>
          </name>
          <article-title>Autophagy: from phenomenology to molecular understanding in less than a decade</article-title>
          <source>Nat Rev Mol Cell Biol</source>
          <year>2007</year>
          <volume>8</volume>
          <fpage>931</fpage>
          <lpage>937</lpage>
          <pub-id pub-id-type="pmid">17712358</pub-id>
        </element-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Rubinsztein</surname>
            <given-names>DC</given-names>
          </name>
          <article-title>The roles of intracellular protein-degradation pathways in neurodegeneration</article-title>
          <source>Nature</source>
          <year>2006</year>
          <volume>443</volume>
          <fpage>780</fpage>
          <lpage>786</lpage>
          <pub-id pub-id-type="pmid">17051204</pub-id>
        </element-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Gu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Cohen</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Effect of IGF-1 on the balance between autophagy of dysfunctional mitochondria and apopto-sis</article-title>
          <source>FEBS Lett</source>
          <year>2004</year>
          <volume>577</volume>
          <fpage>357</fpage>
          <lpage>360</lpage>
          <pub-id pub-id-type="pmid">15556609</pub-id>
        </element-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Melendez</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Talloczy</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Seaman</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Eskelinen</surname>
            <given-names>EL</given-names>
          </name>
          <name>
            <surname>Hall</surname>
            <given-names>DH</given-names>
          </name>
          <name>
            <surname>Levine</surname>
            <given-names>B</given-names>
          </name>
          <article-title>Autophagy genes are essential for dauer development and life-span extension in C. elegans</article-title>
          <source>Science</source>
          <year>2003</year>
          <volume>301</volume>
          <fpage>1387</fpage>
          <lpage>1391</lpage>
          <pub-id pub-id-type="pmid">12958363</pub-id>
        </element-citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Syntichaki</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Troulinaki</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Tavernarakis</surname>
            <given-names>N</given-names>
          </name>
          <article-title>eIF4E function in somatic cells modulates ageing in Caenorhabditis elegans</article-title>
          <source>Nature</source>
          <year>2007</year>
          <volume>445</volume>
          <fpage>922</fpage>
          <lpage>926</lpage>
          <pub-id pub-id-type="pmid">17277769</pub-id>
        </element-citation>
      </ref>
      <ref id="R32">
        <label>32</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Pan</surname>
            <given-names>KZ</given-names>
          </name>
          <name>
            <surname>Palter</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Rogers</surname>
            <given-names>AN</given-names>
          </name>
          <name>
            <surname>Olsen</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lithgow</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Kapahi</surname>
            <given-names>P</given-names>
          </name>
          <article-title>Inhibition of mRNA translation extends lifespan in Caenorhabditis elegans</article-title>
          <source>Aging Cell</source>
          <year>2007</year>
          <volume>6</volume>
          <fpage>111</fpage>
          <lpage>119</lpage>
          <pub-id pub-id-type="pmid">17266680</pub-id>
        </element-citation>
      </ref>
      <ref id="R33">
        <label>33</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Hansen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Taubert</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Crawford</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Libina</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Kenyon</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans</article-title>
          <source>Aging Cell</source>
          <year>2007</year>
          <volume>6</volume>
          <fpage>95</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="pmid">17266679</pub-id>
        </element-citation>
      </ref>
      <ref id="R34">
        <label>34</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Steffen</surname>
            <given-names>KK</given-names>
          </name>
          <name>
            <surname>MacKay</surname>
            <given-names>VL</given-names>
          </name>
          <name>
            <surname>Kerr</surname>
            <given-names>EO</given-names>
          </name>
          <name>
            <surname>Tsuchiya</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Fox</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Dang</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Johnston</surname>
            <given-names>ED</given-names>
          </name>
          <name>
            <surname>Oakes</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Tchao</surname>
            <given-names>BN</given-names>
          </name>
          <name>
            <surname>Pak</surname>
            <given-names>DN</given-names>
          </name>
          <name>
            <surname>Fields</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kennedy</surname>
            <given-names>BK</given-names>
          </name>
          <name>
            <surname>Kaeberlein</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Yeast life span extension by depletion of 60s ribosomal subunits is mediated by Gcn4</article-title>
          <source>Cell</source>
          <year>2008</year>
          <volume>133</volume>
          <fpage>292</fpage>
          <lpage>302</lpage>
          <pub-id pub-id-type="pmid">18423200</pub-id>
        </element-citation>
      </ref>
      <ref id="R35">
        <label>35</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Medvedik</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Lamming</surname>
            <given-names>DW</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>KD</given-names>
          </name>
          <name>
            <surname>Sinclair</surname>
            <given-names>DA</given-names>
          </name>
          <article-title>MSN2 and MSN4 Link Calorie Restriction and TOR to Sirtuin-Mediated Lifespan Extension in Saccharomyces cerevisiae</article-title>
          <source>PLoS Biol</source>
          <year>2007</year>
          <volume>5</volume>
          <fpage>e261</fpage>
          <pub-id pub-id-type="pmid">17914901</pub-id>
        </element-citation>
      </ref>
      <ref id="R36">
        <label>36</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Wei</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Fabrizio</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ge</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Longo</surname>
            <given-names>VD</given-names>
          </name>
          <article-title>Life span extension by calorie restriction depends on Rim15 and transcription factors downstream of Ras/PKA, Tor, and Sch9</article-title>
          <source>PLoS Genet</source>
          <year>2008</year>
          <volume>4</volume>
          <fpage>e13</fpage>
          <pub-id pub-id-type="pmid">18225956</pub-id>
        </element-citation>
      </ref>
      <ref id="R37">
        <label>37</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Bonawitz</surname>
            <given-names>ND</given-names>
          </name>
          <name>
            <surname>Chatenay-Lapointe</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Shadel</surname>
            <given-names>GS</given-names>
          </name>
          <article-title>Reduced TOR signaling extends chronological life span via increased respiration and upregulation of mitochondrial gene expression</article-title>
          <source>Cell Metab</source>
          <year>2007</year>
          <volume>5</volume>
          <fpage>265</fpage>
          <lpage>277</lpage>
          <pub-id pub-id-type="pmid">17403371</pub-id>
        </element-citation>
      </ref>
      <ref id="R38">
        <label>38</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Schieke</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Finkel</surname>
            <given-names>T</given-names>
          </name>
          <article-title>TOR and aging: less is more</article-title>
          <source>Cell Metab</source>
          <year>2007</year>
          <volume>5</volume>
          <fpage>233</fpage>
          <lpage>235</lpage>
          <pub-id pub-id-type="pmid">17403368</pub-id>
        </element-citation>
      </ref>
      <ref id="R39">
        <label>39</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Schieke</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Phillips</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>McCoy</surname>
            <given-names>JPJ</given-names>
          </name>
          <name>
            <surname>Aponte</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>RF</given-names>
          </name>
          <name>
            <surname>Balaban</surname>
            <given-names>RS</given-names>
          </name>
          <name>
            <surname>Finkel</surname>
            <given-names>T</given-names>
          </name>
          <article-title>The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity</article-title>
          <source>J Biol Chem</source>
          <year>2006</year>
          <volume>281</volume>
          <fpage>27643</fpage>
          <lpage>27652</lpage>
          <pub-id pub-id-type="pmid">16847060</pub-id>
        </element-citation>
      </ref>
      <ref id="R40">
        <label>40</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Cunningham</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Rodgers</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Arlow</surname>
            <given-names>DH</given-names>
          </name>
          <name>
            <surname>Vazquez</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Mootha</surname>
            <given-names>VK</given-names>
          </name>
          <name>
            <surname>Puigserver</surname>
            <given-names>P</given-names>
          </name>
          <article-title>mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex</article-title>
          <source>Nature</source>
          <year>2007</year>
          <volume>450</volume>
          <fpage>736</fpage>
          <lpage>740</lpage>
          <pub-id pub-id-type="pmid">18046414</pub-id>
        </element-citation>
      </ref>
      <ref id="R41">
        <label>41</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Bentzinger</surname>
            <given-names>CF</given-names>
          </name>
          <name>
            <surname>Romanino</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>CloÃ«tta</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mascarenhas</surname>
            <given-names>JB</given-names>
          </name>
          <name>
            <surname>Oliveri</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Xia</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Casanova</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Costa</surname>
            <given-names>CF</given-names>
          </name>
          <name>
            <surname>Brink</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Zorzato</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Hall</surname>
            <given-names>MN</given-names>
          </name>
          <name>
            <surname>RÃ¼egg</surname>
            <given-names>MA</given-names>
          </name>
          <article-title>Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy</article-title>
          <source>Cell Metab</source>
          <year>2008</year>
          <volume>8</volume>
          <fpage>411</fpage>
          <lpage>424</lpage>
          <pub-id pub-id-type="pmid">19046572</pub-id>
        </element-citation>
      </ref>
      <ref id="R42">
        <label>42</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Pan</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Shadel</surname>
            <given-names>GS</given-names>
          </name>
          <article-title>Extension of chronological life span by reduced TOR signaling requires down-regulation of Sch9p and involves increased mitochondrial OXPHOS complex density</article-title>
          <source>Aging</source>
          <year>2009</year>
          <volume>1</volume>
          <fpage>131</fpage>
          <lpage>145</lpage>
        </element-citation>
      </ref>
      <ref id="R43">
        <label>43</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Lin</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Kaeberlein</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Andalis</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Sturtz</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Defossez</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Culotta</surname>
            <given-names>VC</given-names>
          </name>
          <name>
            <surname>Fink</surname>
            <given-names>GR</given-names>
          </name>
          <name>
            <surname>Guarente</surname>
            <given-names>L</given-names>
          </name>
          <article-title>Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration</article-title>
          <source>Nature</source>
          <year>2002</year>
          <volume>418</volume>
          <fpage>344</fpage>
          <lpage>348</lpage>
          <pub-id pub-id-type="pmid">12124627</pub-id>
        </element-citation>
      </ref>
      <ref id="R44">
        <label>44</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Khurana</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Steinhilb</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Oldham</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Shulman</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Feany</surname>
            <given-names>MB</given-names>
          </name>
          <article-title>TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model</article-title>
          <source>Curr Biol</source>
          <year>2006</year>
          <volume>16</volume>
          <fpage>230</fpage>
          <lpage>241</lpage>
          <pub-id pub-id-type="pmid">16461276</pub-id>
        </element-citation>
      </ref>
      <ref id="R45">
        <label>45</label>
        <element-citation publication-type="journal">
          <name>
            <surname>An</surname>
            <given-names>WL</given-names>
          </name>
          <name>
            <surname>Cowburn</surname>
            <given-names>RF</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Braak</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Alafuzoff</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Iqbal</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Iqbal</surname>
            <given-names>IG</given-names>
          </name>
          <name>
            <surname>Winblad</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Pei</surname>
            <given-names>JJ</given-names>
          </name>
          <article-title>Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease</article-title>
          <source>Am J Pathol</source>
          <year>2003</year>
          <volume>163</volume>
          <fpage>591</fpage>
          <lpage>607</lpage>
          <pub-id pub-id-type="pmid">12875979</pub-id>
        </element-citation>
      </ref>
      <ref id="R46">
        <label>46</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Berger</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Ravikumar</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Menzies</surname>
            <given-names>FM</given-names>
          </name>
          <name>
            <surname>Oroz</surname>
            <given-names>LG</given-names>
          </name>
          <name>
            <surname>Underwood</surname>
            <given-names>BR</given-names>
          </name>
          <name>
            <surname>Pangalos</surname>
            <given-names>MN</given-names>
          </name>
          <name>
            <surname>Schmitt</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Wullner</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Evert</surname>
            <given-names>BO</given-names>
          </name>
          <name>
            <surname>O'Kane</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Rubinsztein</surname>
            <given-names>DC</given-names>
          </name>
          <article-title>Rapamycin alleviates toxicity of different aggregate-prone proteins</article-title>
          <source>Hum Mol Genet</source>
          <year>2006</year>
          <volume>15</volume>
          <fpage>433</fpage>
          <lpage>442</lpage>
          <pub-id pub-id-type="pmid">16368705</pub-id>
        </element-citation>
      </ref>
      <ref id="R47">
        <label>47</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Rubin</surname>
            <given-names>H</given-names>
          </name>
          <article-title>The disparity between human cell senescence in vitro and lifelong replication in vivo</article-title>
          <source>Nat Biotechnol</source>
          <year>2002</year>
          <volume>20</volume>
          <fpage>675</fpage>
          <lpage>681</lpage>
          <pub-id pub-id-type="pmid">12089551</pub-id>
        </element-citation>
      </ref>
      <ref id="R48">
        <label>48</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Campisi</surname>
            <given-names>J</given-names>
          </name>
          <article-title>The role of cellular senescence in skin aging</article-title>
          <source>J Investig Dermatol Symp Proc</source>
          <year>1998</year>
          <volume>3</volume>
          <fpage>1</fpage>
          <lpage>5</lpage>
        </element-citation>
      </ref>
      <ref id="R49">
        <label>49</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Patil</surname>
            <given-names>CK</given-names>
          </name>
          <name>
            <surname>Mian</surname>
            <given-names>IS</given-names>
          </name>
          <name>
            <surname>Campisi</surname>
            <given-names>J</given-names>
          </name>
          <article-title>The thorny path linking cellular senescence to organismal aging</article-title>
          <source>Mech Ageing Dev</source>
          <year>2005</year>
          <volume>126</volume>
          <fpage>1040</fpage>
          <lpage>1045</lpage>
          <pub-id pub-id-type="pmid">16153470</pub-id>
        </element-citation>
      </ref>
      <ref id="R50">
        <label>50</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Blagosklonny</surname>
            <given-names>MV</given-names>
          </name>
          <article-title>Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition</article-title>
          <source>Cell Cycle</source>
          <year>2006</year>
          <volume>5</volume>
          <fpage>2087</fpage>
          <lpage>2102</lpage>
          <pub-id pub-id-type="pmid">17012837</pub-id>
        </element-citation>
      </ref>
      <ref id="R51">
        <label>51</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Zadrag</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kwolek-Mirek</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bartosz</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bilinski</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Relationship between the replicative age and cell volume in Saccharomyces cerevisiae</article-title>
          <source>Acta Biochim Pol</source>
          <year>2006</year>
          <volume>53(4)</volume>
          <fpage>747</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="pmid">17106513</pub-id>
        </element-citation>
      </ref>
      <ref id="R52">
        <label>52</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Bilinski</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Bartosz</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Hypothesis: Cell volume limits cell divisions</article-title>
          <source>Acta Biochim Pol</source>
          <year>2006</year>
          <volume>53(4)</volume>
          <fpage>833</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">17106512</pub-id>
        </element-citation>
      </ref>
      <ref id="R53">
        <label>53</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Hayflick</surname>
            <given-names>L</given-names>
          </name>
          <article-title>The limited in vitro lifetime of human diploid cell strains</article-title>
          <source>Exp Cell Res</source>
          <year>1965</year>
          <volume>37</volume>
          <fpage>614</fpage>
          <lpage>636</lpage>
          <pub-id pub-id-type="pmid">14315085</pub-id>
        </element-citation>
      </ref>
      <ref id="R54">
        <label>54</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Angello</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Pendergrass</surname>
            <given-names>WR</given-names>
          </name>
          <name>
            <surname>Norwood</surname>
            <given-names>TH</given-names>
          </name>
          <name>
            <surname>Prothero</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Proliferative potential of human fibroblasts: an inverse dependence on cell size</article-title>
          <source>J Cell Physiol</source>
          <year>1987</year>
          <volume>132</volume>
          <fpage>125</fpage>
          <lpage>130</lpage>
          <pub-id pub-id-type="pmid">3597549</pub-id>
        </element-citation>
      </ref>
      <ref id="R55">
        <label>55</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Sherwood</surname>
            <given-names>SW</given-names>
          </name>
          <name>
            <surname>Rush</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ellsworth</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Schimke</surname>
            <given-names>RT</given-names>
          </name>
          <article-title>Defining cellular senescence in IMR-90 cells: a flow cytometric analysis</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>1988</year>
          <volume>85</volume>
          <fpage>9086</fpage>
          <lpage>9090</lpage>
          <pub-id pub-id-type="pmid">3194411</pub-id>
        </element-citation>
      </ref>
      <ref id="R56">
        <label>56</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Echave</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Conlon</surname>
            <given-names>IJ</given-names>
          </name>
          <name>
            <surname>Lloyd</surname>
            <given-names>AC</given-names>
          </name>
          <article-title>Cell size regulation in mammalian cells</article-title>
          <source>Cell Cycle</source>
          <year>2007</year>
          <volume>6</volume>
          <fpage>218</fpage>
          <lpage>224</lpage>
          <pub-id pub-id-type="pmid">17245129</pub-id>
        </element-citation>
      </ref>
      <ref id="R57">
        <label>57</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Pendergrass</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Angello</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Norwood</surname>
            <given-names>TH</given-names>
          </name>
          <article-title>The relationship between cell size, the activity of DNA polymerase alpha and proliferative activity in human diploid fibroblast-like cell cultures</article-title>
          <source>Exp Gerontol</source>
          <year>1989</year>
          <volume>24</volume>
          <fpage>383</fpage>
          <lpage>393</lpage>
          <pub-id pub-id-type="pmid">2632279</pub-id>
        </element-citation>
      </ref>
      <ref id="R58">
        <label>58</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Demidenko</surname>
            <given-names>ZN</given-names>
          </name>
          <name>
            <surname>Blagosklonny</surname>
            <given-names>MV</given-names>
          </name>
          <article-title>Growth stimulation leads to cellular senescence when the cell cycle is blocked</article-title>
          <source>Cell Cycle</source>
          <year>2008</year>
          <volume>7</volume>
          <fpage>3355</fpage>
          <lpage>3361</lpage>
          <pub-id pub-id-type="pmid">18948731</pub-id>
        </element-citation>
      </ref>
      <ref id="R59">
        <label>59</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Demidenko</surname>
            <given-names>ZN</given-names>
          </name>
          <name>
            <surname>Blagosklonny</surname>
            <given-names>MV</given-names>
          </name>
          <article-title>Preservation of proliferative potential versus reversal of cellular hypertrophy as a measure of aging-suppression</article-title>
          <source>Aging</source>
          <year>2009</year>
          <fpage>1</fpage>
        </element-citation>
      </ref>
      <ref id="R60">
        <label>60</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Demidenko</surname>
            <given-names>ZN</given-names>
          </name>
          <name>
            <surname>Zubova</surname>
            <given-names>SG</given-names>
          </name>
          <name>
            <surname>Bukreeva</surname>
            <given-names>EI</given-names>
          </name>
          <name>
            <surname>Pospelov</surname>
            <given-names>VA</given-names>
          </name>
          <name>
            <surname>Pospelova</surname>
            <given-names>TV</given-names>
          </name>
          <name>
            <surname>Blagosklonny</surname>
            <given-names>MV</given-names>
          </name>
          <article-title>Rapamycin decelerates cellular senescence</article-title>
          <source>Cell Cycle</source>
          <year>2009</year>
          <volume>8</volume>
          <fpage>1888</fpage>
          <lpage>1895</lpage>
          <pub-id pub-id-type="pmid">19471117</pub-id>
        </element-citation>
      </ref>
      <ref id="R61">
        <label>61</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Blagosklonny</surname>
            <given-names>MV</given-names>
          </name>
          <article-title>Validation of anti-aging drugs by treating age-related diseases</article-title>
          <source>Aging</source>
          <year>2009</year>
          <volume>1</volume>
          <fpage>281</fpage>
          <lpage>288</lpage>
        </element-citation>
      </ref>
      <ref id="R62">
        <label>62</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Kauffman</surname>
            <given-names>HM</given-names>
          </name>
          <name>
            <surname>Cherikh</surname>
            <given-names>WS</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hanto</surname>
            <given-names>DW</given-names>
          </name>
          <name>
            <surname>Kahan</surname>
            <given-names>BD</given-names>
          </name>
          <article-title>Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies</article-title>
          <source>Transplantation</source>
          <year>2005</year>
          <volume>80</volume>
          <fpage>883</fpage>
          <lpage>889</lpage>
          <pub-id pub-id-type="pmid">16249734</pub-id>
        </element-citation>
      </ref>
      <ref id="R63">
        <label>63</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Yakupoglu</surname>
            <given-names>YK</given-names>
          </name>
          <name>
            <surname>Buell</surname>
            <given-names>JF</given-names>
          </name>
          <name>
            <surname>Woodle</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kahan</surname>
            <given-names>BD</given-names>
          </name>
          <article-title>Individualization of Immunosuppressive Therapy. III. Sirolimus Associated With a Reduced Incidence of Malignancy</article-title>
          <source>Transplant Proc</source>
          <year>2006</year>
          <volume>38</volume>
          <fpage>358</fpage>
          <lpage>361</lpage>
          <pub-id pub-id-type="pmid">16549120</pub-id>
        </element-citation>
      </ref>
      <ref id="R64">
        <label>64</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Campistol</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Eris</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Oberbauer</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Friend</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Hutchison</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Morales</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Claesson</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Stallone</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Russ</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Rostaing</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Kreis</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Burke</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Brault</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Scarola</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Neylan</surname>
            <given-names>JF</given-names>
          </name>
          <article-title>Sirolimus Therapy after Early Cyclosporine Withdrawal Reduces the Risk for Cancer in Adult Renal Transplantation</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2006</year>
          <volume>17</volume>
          <fpage>581</fpage>
          <lpage>589</lpage>
          <pub-id pub-id-type="pmid">16434506</pub-id>
        </element-citation>
      </ref>
      <ref id="R65">
        <label>65</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Stallone</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Schena</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Infante</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Di Paolo</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Loverre</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Maggio</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Ranieri</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Gesualdo</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Schena</surname>
            <given-names>FP</given-names>
          </name>
          <name>
            <surname>Grandaliano</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Sirolimus for Kaposi's sarcoma in renal-transplant recipients</article-title>
          <source>N Engl J Med</source>
          <year>2005</year>
          <volume>352</volume>
          <fpage>1317</fpage>
          <lpage>1323</lpage>
          <pub-id pub-id-type="pmid">15800227</pub-id>
        </element-citation>
      </ref>
      <ref id="R66">
        <label>66</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Pascual</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>FernÃ¡ndez</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>MarcÃ©n</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>OrtuÃ±o</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Conversion to everolimus in a patient with arterial hypertension and recurrent cutaneous neoplasia - a case report</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>2006</year>
          <volume>21</volume>
          <fpage>iii38</fpage>
          <lpage>iii41</lpage>
          <pub-id pub-id-type="pmid">16815857</pub-id>
        </element-citation>
      </ref>
      <ref id="R67">
        <label>67</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Rovira</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Marcelo</surname>
            <given-names>Arellano E</given-names>
          </name>
          <name>
            <surname>Burke</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Brault</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Moya-Rull</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>BanÃ³n-Maneus</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>RamÃ­rez-Bajo</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>GutiÃ©rrez-Dalmau</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Revuelta</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Quintana</surname>
            <given-names>LF</given-names>
          </name>
          <name>
            <surname>Campistol</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Diekmann</surname>
            <given-names>F</given-names>
          </name>
          <article-title>Effect of mTOR inhibitor on body weight: from an experimental rat model to human transplant patients</article-title>
          <source>Transpl Int</source>
          <year>2008</year>
          <volume>21</volume>
          <fpage>992</fpage>
          <lpage>998</lpage>
          <pub-id pub-id-type="pmid">18657090</pub-id>
        </element-citation>
      </ref>
      <ref id="R68">
        <label>68</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Leelahavanichkul</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Areepium</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Vadcharavivad</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Praditpornsilpa</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Avihingsanon</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Karnjanabuchmd</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Eiam-Ong</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Tungsanga</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Pharmacokinetics of sirolimus in Thai healthy volunteers</article-title>
          <source>J Med Assoc Thai</source>
          <year>2005</year>
          <volume>88</volume>
          <fpage>S157</fpage>
          <lpage>162</lpage>
          <pub-id pub-id-type="pmid">16623021</pub-id>
        </element-citation>
      </ref>
      <ref id="R69">
        <label>69</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Leung</surname>
            <given-names>LY</given-names>
          </name>
          <name>
            <surname>Lim</surname>
            <given-names>HK</given-names>
          </name>
          <name>
            <surname>Abell</surname>
            <given-names>MW</given-names>
          </name>
          <name>
            <surname>Zimmerman</surname>
            <given-names>JJ</given-names>
          </name>
          <article-title>Pharmacokinetics and Metabolic Disposition of Sirolimus in Healthy Male Volunteers After a Single Oral Dose</article-title>
          <source>Ther Drug Monit</source>
          <year>2006</year>
          <volume>28</volume>
          <fpage>51</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="pmid">16418694</pub-id>
        </element-citation>
      </ref>
      <ref id="R70">
        <label>70</label>
        <element-citation publication-type="journal">
          <name>
            <surname>Krebs</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Brunmair</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Brehm</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Artwohl</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Szendroedi</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Nowotny</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Roth</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>FÃ¼rnsinn</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Promintzer</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Anderwald</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Bischof</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Roden</surname>
            <given-names>M</given-names>
          </name>
          <article-title>The Mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man</article-title>
          <source>Diabetes</source>
          <year>2007</year>
          <volume>56</volume>
          <fpage>1600</fpage>
          <lpage>1607</lpage>
          <pub-id pub-id-type="pmid">17329620</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn fn-type="conflict">
        <p>The authors declare no conflict of interests.
                        
                </p>
      </fn>
    </fn-group>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>